Clinical Immunology and Allergy Section (CIAS)
The BSI has a special section within the Society, which particularly focuses on the priorities and needs of its clinical members.
Membership is open and inclusive of those involved in Clinical Immunology and Allergy, including nurses in immunology and allergy, biomedical scientists, clinical scientists, researchers, trainees, and clinical immunologists and allergists. It is NOT intended to be a section solely for consultant clinical immunologists, or to replace activities of other professional organisations such as ACSI/IBMS etc., but to provide a unique single, authoritative, well-funded forum for all practitioners of Immunology, to interact for the benefit of the speciality, with access to the facilities, kudos and support of a major international scientific society.
Members who have an interest in clinical matters are invited to join the CIAS by updating their membership profile
Organisation of the CIAS
The formation of the CIAS was approved by the BSI's Board of Trustees in 2006. We now have a Clinical Secretary
on board, who is the Chair of the CIAS Executive Committee
, formed of nominated representatives from key organisations.
Aims of the CIAS:
- To foster excellence in the practice of immunological medicine
- The creation of a section of the BSI able to represent the wider Clinical Immunology and Allergy community
- To reduce fragmentation, and allow the community to speak with one voice at trust, college and Department of Health level
- To enhance communication between the scientific and Clinical Immunology communities
Please click here
to view the full constitution of the CIAS. Minutes from the CIAS Executive Committee are available here
(please note that you must be logged in to access these documents).
Improving Quality in Allergy Services (IQAS) accreditation scheme
Quality in Primary Immunodeficiency Services (QPIDS) accreditation scheme
The IQAS registration scheme was initially launched in 2011 by the Royal College of Physicians (RCP) and Royal College of Pathologists Joint Committee on Immunology and Allergy (JCIA). This has now been developed into a full accreditation scheme, run by the Royal College of Physicians. The IQAS standards are based on those set out in the allergy chapter of the RCP’s blueprint for medical services in hospitals, and expert opinion from the allergy community.
The QPIDS accreditation scheme originally launched under the UK Primary Immunodeficiency Network (UKPIN), and transferred to the Royal College of Physicians in 2015. The standards have been revised but remain largely the same as under UKPIN, while the accreditation pathway has been revised to follow the methodology of
the RCP’s accreditation unit.
To become accredited, services must undertake a self-assessment against the relevant scheme’s standards and commence a self-led program of quality improvement. When services believe they meet the standards they undergo a remote assessment, where their evidence is reviewed online by an assessment team, before an on-site assessment of the service and facilities. If the standards are found to have been met then services are accredited for five years, subject to an annual renewal assessment.
The clinical lead for the IQAS scheme is Dr M. Thirumala Krishna, consultant allergist and immunologist from Birmingham Heartlands Hospital and the clinical lead for the QPIDS scheme is Dr Claire Bethune, consultant immunologist from Plymouth Hospitals NHS Trust. For more information on the schemes, please see the IQAS website
or the QPIDS website
, or contact [email protected]
Please contact Emilie Thomas
if you wish to obtain more information on the CIAS.